BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Shi-Min Luo, Li-Jian Liang, Jia-Ming Lai. Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosisWorld Journal of Gastroenterology 2004; 10(9): 1292-1296 doi: 10.3748/wjg.v10.i9.1292
2
Geng Tian, Ji-Lin Yi, Ping Xiong. Antitumor immunopreventive effect in mice induced by DNA vaccine encoding a fusion protein of α-fetoprotein and CTLA4World Journal of Gastroenterology 2004; 10(2): 200-204 doi: 10.3748/wjg.v10.i2.200
3
Hansheng Liu, Aiqun Zhang, Niansong Qian, Lijie Gao, Lining Xu, Wenzhi Zhang, Kai Jiang, Shouwang Cai, Zhiqiang Huang, Jiahong Dong. Postoperative Transarterial Chemoembolization Benefits Patients with High ^|^gamma;-Glutamyl Transferase Levels after Curative Hepatectomy for Hepatocellular Carcinoma: A Survival Stratification AnalysisThe Tohoku Journal of Experimental Medicine 2012; 227(4): 269 doi: 10.1620/tjem.227.269
4
Andrea Horvath, Aniko Folhoffer, Peter Laszlo Lakatos, Judit Halász, Gyorgy Illyés, Zsuzsa Schaff, Monika Beatrix Hantos, Kornelia Tekes, Ferenc Szalay. Rising plasma nociceptin level during development of HCC: A case reportWorld Journal of Gastroenterology 2004; 10(1): 152-154 doi: 10.3748/wjg.v10.i1.152
5
Dai Hoon Han, Sung Hoon Choi, Eun Jung Park, Dae Ryong Kang, Gi Hong Choi, Jin Sub Choi. Surgical outcomes after laparoscopic or robotic liver resection in hepatocellular carcinoma: a propensity-score matched analysis with conventional open liver resectionThe International Journal of Medical Robotics and Computer Assisted Surgery 2016; 12(4): 735 doi: 10.1002/rcs.1714
6
Dong Do You, Dong Goo Kim, Chang Ho Seo, Ho Joong Choi, Young Kyung Yoo, Yong Gyu Park. Prognostic factors after curative resection hepatocellular carcinoma and the surgeon's roleAnnals of Surgical Treatment and Research 2017; 93(5): 252 doi: 10.4174/astr.2017.93.5.252
7
Yong-Song Guan, Ying Hu, Yuan Liu. Multidetector-row computed tomography in the management of hepatocellular carcinoma with transcatheter arterial chemoembolizationJournal of Gastroenterology and Hepatology 2006; 21(6): 941 doi: 10.1111/j.1440-1746.2006.04474.x
8
Si-Hai Chen, Qin-Si Wan, Di Zhou, Ting Wang, Jia Hu, Yu-Ting He, Hai-Liang Yuan, Yu-Qi Wang, Kun-He Zhang. A Simple-to-Use Nomogram for Predicting the Survival of Early Hepatocellular Carcinoma PatientsFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00584
9
Zhao-Chong Zeng, Jia Fan, Zhao-You Tang, Jian Zhou, Lun-Xiu Qin, Jian-Hua Wang, Hui-Chuan Sun, Bin-Liang Wang, Jian-Ying Zhang, Guo-Liang Jiang, Yu-Qi Wang. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombusInternational Journal of Radiation Oncology*Biology*Physics 2005; 61(2): 432 doi: 10.1016/j.ijrobp.2004.05.025
10
Xin-Da Zhou, Zhao-You Tang, Zeng-Chen Ma, Jia Fan, Zhi-Quan Wu, Lun-Xiu Qin, Jian Zhou, Yao Yu, Hui-Chuan Sun, Shuang-Jian Qiu. Twenty-year survivors after resection for hepatocellular carcinoma-analysis of 53 casesJournal of Cancer Research and Clinical Oncology 2009; 135(8): 1067 doi: 10.1007/s00432-009-0546-z
11
Alpaslan Tanoglu, Ergenekon Karagoz. Predictive Role of the Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Hepatocellular Carcinoma Receiving SorafenibAsian Pacific Journal of Cancer Prevention 2014; 15(2): 1063 doi: 10.7314/APJCP.2014.15.2.1063
12
Young-Joo Jin, Young-Hwa Chung, Jeong A. Kim, Won Hyung Park, Danbi Lee, Dong Dae Seo, Soo Hyung Ryu, Myoung Kuk Jang, Eunsil Yu, Young Joo Lee. Factors Predisposing Metastatic Tumor Antigen 1 Overexpression in Hepatitis B Virus Associated Hepatocellular CarcinomaDigestive Diseases and Sciences 2012; 57(11): 2917 doi: 10.1007/s10620-012-2296-z
13
Ning Ren, Qing-Hai Ye, Lun-Xiu Qin, Bo-Heng Zhang, Yin-Kun Liu, Zhao-You Tang. Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patientsWorld Journal of Gastroenterology 2006; 12(24): 3911-3914 doi: 10.3748/wjg.v12.i24.3911
14
Li-Wang Zhang, Jun Ren, Liang Zhang, Hong-Mei Zhang, Bin Jin, Bo-Rong Pan, Xiao-Ming Si, Yan-Jun Zhang, Zhong-Hua Wang, Yang-Lin Pan, Stephen M Festein. Construction and expression of recombined human AFP eukaryotic expression vectorWorld Journal of Gastroenterology 2003; 9(7): 1465-1468 doi: 10.3748/wjg.v9.i7.1465
15
M.A. Hayat. Handbook of Immunohistochemistry and in situ Hybridization of Human Carcinomas, Volume 3 - Molecular Genetics, Liver Carcinoma, and Pancreatic CarcinomaHandbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas 2005; 3: 131 doi: 10.1016/S1874-5784(05)80018-2
16
Ming-Chin Yu, Yun-Shien Lee, Sey-En Lin, Hsiang-Yao Wu, Tse-Ching Chen, Wei-Chen Lee, Miin-Fu Chen, Chi-Neu Tsai. Recurrence and Poor Prognosis Following Resection of Small Hepatitis B-Related Hepatocellular Carcinoma Lesions Are Associated with Aberrant Tumor Expression Profiles of Glypican 3 and OsteopontinAnnals of Surgical Oncology 2012; 19(S3): 455 doi: 10.1245/s10434-011-1946-2
17
Kuo-Shyang Jeng, I-Shyan Sheen, Yi-Chun Tsai. Does the Presence of Circulating Hepatocellular Carcinoma Cells Indicate a Risk of Recurrence after Resection?The American Journal of Gastroenterology 2004; 99(8): 1503 doi: 10.1111/j.1572-0241.2004.30227.x
18
Juqiang Han, Xiaojie Xu, Hongzhen Qin, Anheng Liu, Zhongyi Fan, Lei Kang, Jing Fu, Jiahong Liu, Qinong Ye. The molecular mechanism and potential role of heat shock-induced p53 protein accumulationMolecular and Cellular Biochemistry 2013; 378(1-2): 161 doi: 10.1007/s11010-013-1607-9
19
Makoto Nakamuta, Shusuke Morizono, Motoyuki Kohjima, Kazuhiro Kotoh, Munechika Enjoji. Baseline characterization of patients aged 70 years and above with hepatocellular carcinomaWorld Journal of Gastroenterology 2005; 11(47): 7512-7514 doi: 10.3748/wjg.v11.i47.7512
20
Dai Hoon Han, Gi Hong Choi, Kyung Sik Kim, Jin Sub Choi, Young Nyun Park, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Kwang-Hyub Han. Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiationJournal of Gastroenterology and Hepatology 2013; 28(8): 1384 doi: 10.1111/jgh.12200
21
Sui-Hai Si, Jian-Min Yang, Zhi-Hong Peng, Yuan-Hui Luo, Ping Zhou. Effects of KAI1 gene on growth and invasion of human hepatocellular carcinoma MHCC97-H cellsWorld Journal of Gastroenterology 2004; 10(14): 2019-2023 doi: 10.3748/wjg.v10.i14.2019
22
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 151 doi: 10.1007/978-3-319-26956-6_6
23
Tsung-Han Wu, Ming-Chin Yu, Tse-Ching Chen, Chen-Fang Lee, Kun-Ming Chan, Ting-Jung Wu, Hong-Shiue Chou, Wei-Chen Lee, Miin-Fu Chen. Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinomaJournal of Surgical Oncology 2012; 105(1): 85 doi: 10.1002/jso.22060
24
Y. Choi, J. W. Kim, H. Cha, K. H. Han, J. Seong. Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapyJournal of Radiation Research 2014; 55(1): 113 doi: 10.1093/jrr/rrt082
25
Hong-Chi Jiang, Lian-Xin Liu, Da-Xun Piao, Jun Xu, Min Zheng, An-Long Zhu, Shu-Yi Qi, Wei-Hui Zhang, Lin-Feng Wu. Clinical short-term results of radiofrequency ablation in liver cancersWorld Journal of Gastroenterology 2002; 8(4): 624-630 doi: 10.3748/wjg.v8.i4.624
26
Zu-Hua Gao. Predictive markers for postsurgical recurrence of hepatocellular carcinomaJournal of Surgical Oncology 2005; 92(4): 274 doi: 10.1002/jso.20389
27
Runzhou Ni, Mingbing Xiao, Fei Jin, Cuihua Lu, Jiefei Huang, Xianyong Meng. Clinical value of hepatoma-specific alpha-fetoprotein in the diagnosis of hepatocellular carcinomaChinese Journal of Clinical Oncology 2006; 3(3): 153 doi: 10.1007/s11805-006-0109-x
28
Kosuke Matsui, Masaki Kaibori, Morihiko Ishizaki, A-Hon Kwon. Microwave coagulation therapy for huge hepatocellular carcinoma with liver cirhosisJournal of Microwave Surgery 2011; 29: 127 doi: 10.3380/jmicrowavesurg.29.127
29
S. Jayaraman, A. Khakhar, H. Yang, D. Bainbridge, D. Quan. The association between central venous pressure, pneumoperitoneum, and venous carbon dioxide embolism in laparoscopic hepatectomySurgical Endoscopy 2009; 23(10): 2369 doi: 10.1007/s00464-009-0359-9
30
Rong-Xin Chen, Yun-Hong Xia, Jie-Feng Cui, Tong-Chun Xue, Sheng-Long Ye. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resectionJournal of Gastroenterology and Hepatology 2010; 25(8): 1435 doi: 10.1111/j.1440-1746.2010.06277.x
31
D.S.R. Lockwood, D.C. Gotley. Integration/Interaction of Oncologic GrowthCancer Growth and Progression 2005; 15: 165 doi: 10.1007/1-4020-3414-8_9
32
Lian-Xin Liu, Hong-Chi Jiang, Zhi-Hua Liu, Jing Zhou, Wei-Hui Zhang, An-Long Zhu, Xiu-Qin Wang, Min Wu. Intergrin gene expression profiles of humanhepatocellular carcinomaWorld Journal of Gastroenterology 2002; 8(4): 631-637 doi: 10.3748/wjg.v8.i4.631
33
Jae Gil Lee, Chang Mu Kang, Joon Seong Park, Kyung Sik Kim, Dong Sup Yoon, Jin Sub Choi, Woo Jung Lee, Byong Ro Kim. The Actual Five-year Survival Rate of Hepatocellular Carcinoma Patients after Curative ResectionYonsei Medical Journal 2006; 47(1): 105 doi: 10.3349/ymj.2006.47.1.105
34
Xiaojie Xu, Chengying Jiang, Shibin Wang, Yanhong Tai, Tao Wang, Lei Kang, Zhongyi Fan, Shuyue Li, Ling Li, Jing Fu, Jiahong Liu, Quanbo Ji, Xuan Wang, Lixin Wei, Qinong Ye. HPIP is upregulated in liver cancer and promotes hepatoma cell proliferation via activation of G2/M transitionIUBMB Life 2013; : n/a doi: 10.1002/iub.1202
35
Priya Mathews, Danbi Lee, Young-Hwa Chung, Jeong A. Kim, Ju-Ho Lee, Young-Joo Jin, Wonhyung Park, Heather Lyu, Elizabeth Jaffee, Lei Zheng, Eunsil Yu, Young Joo Lee. Effects of Genomic Changes in Hepatitis B Virus on Postoperative Recurrence and Survival in Patients with Hepatocellular CarcinomaAnnals of Surgical Oncology 2013; 20(4): 1216 doi: 10.1245/s10434-012-2706-7
36
Run-Zhou Ni, Jie-Fei Huang, Ming-Bing Xiao, Mei Li, Xian-Yong Meng. Glycylproline dipeptidyl aminopeptidase isoenzyme in diagnosis of primary hepatocellular carcinomaWorld Journal of Gastroenterology 2003; 9(4): 710-713 doi: 10.3748/wjg.v9.i4.710
37
Lian-Xin Liu, Hong-Chi Jiang, Da-Xun Piao. Radiofrequence ablation of liver cancersWorld Journal of Gastroenterology 2002; 8(3): 393-399 doi: 10.3748/wjg.v8.i3.393
38
Charles E. Woodall, Charles R. Scoggins, Jennifer Loehle, Kadiyala V. Ravindra, Kelly M. McMasters, Robert C. G. Martin. Hepatic Imaging Characteristics Predict Overall Survival in Hepatocellular CarcinomaAnnals of Surgical Oncology 2007; 14(10): 2824 doi: 10.1245/s10434-007-9525-2
39
Yun-Le Wan, Shu-Sen Zheng, Zhi-Cheng Zhao, Min-Wei Li, Chang-Ku Jia, Hao Zhang. Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunityWorld Journal of Gastroenterology 2004; 10(2): 195-199 doi: 10.3748/wjg.v10.i2.195
40
Wu Ji, Jie-Shou Li, Ling-Tang Li, Wu-Hong Liu, Kuan-Sheng Ma, Xiang-Tian Wang, Zhen-Ping He, Jia-Hong Dong. Role of preoperative selective portal vein embolization in two-step curative hepatectomy for hepatocellular carcinomaWorld Journal of Gastroenterology 2003; 9(8): 1702-1706 doi: 10.3748/wjg.v9.i8.1702
41
Zhao-Chong Zeng, Zhao-You Tang, Jia Fan, Jian Zhou, Lun-Xiu Qin, Shen-Long Ye, Hui-Chuan Sun, Bin-Liang Wang, Yao Yu, Jian-Hua Wang, Wei Guo. A Comparison of Chemoembolization Combination With and Without Radiotherapy for Unresectable Hepatocellular CarcinomaThe Cancer Journal 2004; 10(5): 307 doi: 10.1097/00130404-200409000-00008
42
Ali Zarrinpar, Un Bi Kim, Vijay Boominathan. Phenotypic Response and Personalized Medicine in Liver Cancer and Transplantation: Approaches to Complex SystemsAdvanced Therapeutics 2020; : 1900167 doi: 10.1002/adtp.201900167
43
Chang-Xin Geng, Zhao-Chong Zeng, Ji-Yao Wang. Docetaxel inhibits SMMC-7721 human hepatocellular carcinoma cells growth and induces apoptosisWorld Journal of Gastroenterology 2003; 9(4): 696-700 doi: 10.3748/wjg.v9.i4.696
44
Myeong Jun Song, Chan Kwon Jung, Chung-Hwa Park, Wonhee Hur, Jung Eun Choi, Si Hyun Bae, Jong Young Choi, Sang Wook Choi, Nam Ik Han, Seung Kew Yoon. RPL36 as a prognostic marker in hepatocellular carcinomaPathology International 2011; 61(11): 638 doi: 10.1111/j.1440-1827.2011.02716.x
45
Shao-Shan Wang, Ti Zhang, Xi-Lu Wang, Li Hong, Qing-Hui Qi. Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicityWorld Journal of Gastroenterology 2003; 9(5): 930-935 doi: 10.3748/wjg.v9.i5.930
46
Wen-Hua Xiao, Wei-Wen Liu. Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinomaWorld Journal of Gastroenterology 2004; 10(3): 376-380 doi: 10.3748/wjg.v10.i3.376
47
Archana Rastogi. Changing role of histopathology in the diagnosis and management of hepatocellular carcinomaWorld Journal of Gastroenterology 2018; 24(35): 4000-4013 doi: 10.3748/wjg.v24.i35.4000
48
Hu Liu, Sheng-Long Ye, Jiong Yang, Zhao-You Tang, Yin-Kun Liu, Lun-Xiu Qin, Shuang-Jian Qiu, Rui-Xia Sun. The microcell mediated transfer of human chromosome 8 into highly metastatic rat liver cancer cell line C5FWorld Journal of Gastroenterology 2003; 9(3): 449-453 doi: 10.3748/wjg.v9.i3.449
49
Shu-Min Zhang, Zhao-Chong Zeng, Zhao-You Tang, Jing Sun, Jie-Min Cheng, Rong Liu, Ping Wang, Bo-Heng Zhang. Prognostic analysis of pulmonary metastases from hepatocellular carcinomaHepatology International 2008; 2(2): 237 doi: 10.1007/s12072-008-9052-7
50
Kenji Kashima, Miho Watanabe, Yasuko Satoh, Junichi Hata, Nobuya Ishii, Yuko Aoki. Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor-DCancer Science 2012; 103(12): 2144 doi: 10.1111/cas.12010
51
Luca Di Tommaso, Marco Spadaccini, Matteo Donadon, Nicola Personeni, Abubaker Elamin, Alessio Aghemo, Ana Lleo. Role of liver biopsy in hepatocellular carcinomaWorld Journal of Gastroenterology 2019; 25(40): 6041-6052 doi: 10.3748/wjg.v25.i40.6041
52
Mei-Sze Chua, Hongbo Sun, Siu T Cheung, Veronica Mason, John Higgins, Douglas T Ross, Sheung T Fan, Samuel So. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinomaModern Pathology 2007; 20(1): 76 doi: 10.1038/modpathol.3800711
53
Hui-Ting Hsu, Pei-Ru Wu, Chih-Jung Chen, Li-Sung Hsu, Chung-Min Yeh, Ming-Tai Hsing, Yi-Shan Chiang, Ming-Tsung Lai, Kun-Tu Yeh. High Cytoplasmic Expression of Krüppel-like Factor 4 Is an Independent Prognostic Factor of Better Survival in Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2014; 15(6): 9894 doi: 10.3390/ijms15069894
54
Wei Wang, Lian-Yue Yang, Zhi-Li Yang, Gen-Wen Huang, Wei-Qun Lu. Expression and significance of RhoC gene in hepatocellular carcinomaWorld Journal of Gastroenterology 2003; 9(9): 1950-1953 doi: 10.3748/wjg.v9.i9.1950
55
Jun-Fei Jin, Liu-Di Yuan, Li Liu, Zhu-Jiang Zhao, Wei Xie. Preparation and characterization of polyclonal antibodies against ARL-1 proteinWorld Journal of Gastroenterology 2003; 9(7): 1455-1459 doi: 10.3748/wjg.v9.i7.1455
56
Ferenc Szalay, Mónika B Hantos, Andrea Horvath, Peter L. Lakatos, Aniko Folhoffer, Kinga Dunkel, Dalma Hegedus, Kornélia Tekes. Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinomaWorld Journal of Gastroenterology 2004; 10(1): 42-45 doi: 10.3748/wjg.v10.i1.42
57
Jun Qian, Gan-Sheng Feng, Thomas Vogl. Combined interventional therapies of hepatocellular carcinomaWorld Journal of Gastroenterology 2003; 9(9): 1885-1891 doi: 10.3748/wjg.v9.i9.1885
58
Noriaki Morofuji, Hidenori Ojima, Nobuyoshi Hiraoka, Takuji Okusaka, Minoru Esaki, Satoshi Nara, Kazuaki Shimada, Yoshiro Kishi, Tadashi Kondo. Antibody-based proteomics to identify an apoptosis signature for early recurrence of hepatocellular carcinomaClinical Proteomics 2016; 13(1) doi: 10.1186/s12014-016-9130-0
59
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_6-1
60
Quan-Da Liu, Kuan-Sheng Ma, Zhen-Ping He, Jun Ding, Xue-Quan Huang, Jia-Hong Dong. Experimental study on the feasibility and safety of radiofrequency ablation for secondary splenomagely and hypersplenismWorld Journal of Gastroenterology 2003; 9(4): 813-817 doi: 10.3748/wjg.v9.i4.813
61
Lian-yue Yang, Wei-qun Lu, Geng-wen Huang, Wei Wang. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinomaBMC Cancer 2006; 6(1) doi: 10.1186/1471-2407-6-110
62
Junichi Zaitsu, Takahiro Yamasaki, Issei Saeki, Yohei Harima, Takuya Iwamoto, Yumiko Harima, Toshihiko Matsumoto, Yohei Urata, Isao Hidaka, Yoshio Marumoto, Tsuyoshi Ishikawa, Taro Takami, Naoki Yamamoto, Seiji Kaino, Koichi Uchida, Shuji Terai, Isao Sakaida. Serum transferrin as a predictor of prognosis for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinomaHepatology Research 2014; 44(5): 481 doi: 10.1111/hepr.12141
63
Yu Lei, Qiaoling Hu, Jiang Gu. Expressions of Carbohydrate Response Element Binding Protein and Glucose Transporters in Liver Cancer and Clinical SignificancePathology & Oncology Research 2019;  doi: 10.1007/s12253-019-00708-y
64
Chenfeng Xu, Yu Ding, Jiang Ni, Lifang Yin, Jianping Zhou, Jing Yao. Tumor-targeted docetaxel-loaded hyaluronic acid-quercetin polymeric micelles with p-gp inhibitory property for hepatic cancer therapyRSC Advances 2016; 6(33): 27542 doi: 10.1039/C6RA00460A
65
WILLIAM KEMP, STEPHEN PIANKO, SHARA NGUYEN, MICHAEL J BAILEY, STUART K ROBERTS. Survival in hepatocellular carcinoma: Impact of screening and etiology of liver diseaseJournal of Gastroenterology and Hepatology 2005; 20(6): 873 doi: 10.1111/j.1440-1746.2005.03844.x
66
Yi Jilin, Tian Geng. Gene cloning of murine α-fetoprotein gene and construction of its eukaryotic expression vector and expression in CHO cellsJournal of Huazhong University of Science and Technology [Medical Sciences] 2003; 23(4): 392 doi: 10.1007/BF02829426
67
Haixiao Wang, Kuangjie Wu, Yuan Sun, Yandong Li, Mingyu Wu, Qian Qiao, Yuanjiang Wei, Ze-Guang Han, Bing Cai. STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitroBMB Reports 2012; 45(11): 629 doi: 10.5483/BMBRep.2012.45.11.086
68
Dao-Yong Liu, Zhi-Hai Peng, Guo-Qiang Qiu, Chong-Zhi Zhou. Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosisWorld Journal of Gastroenterology 2003; 9(8): 1859-1862 doi: 10.3748/wjg.v9.i8.1859
69
Yu-Chen Hsu, Hsiao-Hui Fu, Yung-Ming Jeng, Po-Huang Lee, Shiaw-Der Yang. Proline-Directed Protein Kinase FA Is a Powerful and Independent Prognostic Predictor for Progression and Patient Survival of Hepatocellular CarcinomaJournal of Clinical Oncology 2006; 24(23): 3780 doi: 10.1200/JCO.2005.03.7499
70
Christian Melle, Günther Ernst, Olaf Scheibner, Roland Kaufmann, Bettina Schimmel, Annett Bleul, Utz Settmacher, Merten Hommann, Uwe Claussen, Ferdinand von Eggeling. Identification of Specific Protein Markers in Microdissected Hepatocellular CarcinomaJournal of Proteome Research 2007; 6(1): 306 doi: 10.1021/pr060439b
71
Dong Xu, De-Ying Tian, Zhen-Gang Zhang, Hong-Yun Chen, Pei-Hui Song. Effect of SEN virus coinfection on outcome of lamivudine therapy in patients with hepatitis BWorld Journal of Gastroenterology 2004; 10(7): 968-971 doi: 10.3748/wjg.v10.i7.968
72
Ning Ren, Lun-Xiu Qin, Hong Tu, Yin-Kun Liu, Bo-Heng Zhang, Zhao-You Tang. The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology 2006; 132(6): 399 doi: 10.1007/s00432-005-0049-5
73
Zimin Liu, Huamin Liu, Huazheng Pan, Qihang Du, Jun Liang. Clinicopathological significance of S100A4 expression in human hepatocellular carcinomaJournal of International Medical Research 2013; 41(2): 457 doi: 10.1177/0300060513478086
74
Takayuki Shimizu, Mitsuru Ishizuka, Takashi Suzuki, Genki Tanaka, Kyung Hwa Park, Takatsugu Matsumoto, Takayuki Shiraki, Yuhki Sakuraoka, Masato Kato, Taku Aoki, Keiichi Kubota. The preoperative globulin-to-albumin ratio, a novel inflammation-based prognostic system, predicts survival after potentially curative liver resection for patients with hepatocellular carcinomaJournal of Surgical Oncology 2017; 116(8): 1166 doi: 10.1002/jso.24772
75
Young Kon Kim, Hyo Sung Kwak, Chong Soo Kim, Gyung Ho Chung, Young Min Han, Jeong Min Lee. Hepatocellular Carcinoma in Patients with Chronic Liver Disease: Comparison of SPIO-enhanced MR Imaging and 16–Detector Row CTRadiology 2006; 238(2): 531 doi: 10.1148/radiol.2381042193
76
Luciana dos Santos Schraiber, Angelo Alves de Mattos, Maria Lucia Zanotelli, Guido Pio Cracco Cantisani, Ajácio Bandeira de Mello Brandão, Cludio Augusto Marroni, Guilhermo Kiss, Lucas Ernani, Patrícia dos Santos Marcon. Alpha-fetoprotein Level Predicts Recurrence After Transplantation in Hepatocellular CarcinomaMedicine 2016; 95(3): e2478 doi: 10.1097/MD.0000000000002478
77
Zhan-Hong Chen, Ying-Fen Hong, Jinxiang Lin, Xing Li, Dong-Hao Wu, Jing-Yun Wen, Jie Chen, Dan-Yun Ruan, Qu Lin, Min Dong, Li Wei, Tian-Tian Wang, Ze-Xiao Lin, Xiao-Kun Ma, Xiang-Yuan Wu, Ruihua Xu. Validation and ranking of seven staging systems of hepatocellular carcinomaOncology Letters 2017; 14(1): 705 doi: 10.3892/ol.2017.6222
78
Yun-peng Hao, Zheng-yu Liu, Cheng Xie, Lu Zhou, Xun Sun. Novel fluorinated docetaxel analog for anti-hepatoma: Molecular docking and biological evaluationEuropean Journal of Pharmaceutical Sciences 2016; 88: 274 doi: 10.1016/j.ejps.2016.03.022
79
Shi-Jian Ding, Yan Li, Ye-Xiong Tan, Man-Rong Jiang, Bo Tian, Ying-Kun Liu, Xiao-Xia Shao, Sheng-Long Ye, Jia-Rui Wu, Rong Zeng, Hong-Yang Wang, Zhao-You Tang, Qi-Chang Xia. From Proteomic Analysis to Clinical SignificanceMolecular & Cellular Proteomics 2004; 3(1): 73 doi: 10.1074/mcp.M300094-MCP200
80
Tomohiro Iguchi, Shinichi Aishima, Kensaku Sanefuji, Nobuhiro Fujita, Keishi Sugimachi, Tomonobu Gion, Akinobu Taketomi, Ken Shirabe, Yoshihiko Maehara, Masazumi Tsuneyoshi. Both Fibrous Capsule Formation and Extracapsular Penetration Are Powerful Predictors of Poor Survival in Human Hepatocellular Carcinoma: A Histological Assessment of 365 Patients in JapanAnnals of Surgical Oncology 2009; 16(9): 2539 doi: 10.1245/s10434-009-0453-1
81
Brian I. Carr, Petr Pancoska, Edoardo G. Giannini, Fabio Farinati, Francesca Ciccarese, Gian Ludovico Rapaccini, Maria Di Marco, Luisa Benvegnù, Marco Zoli, Franco Borzio, Eugenio Caturelli, Maria Chiaramonte, Franco Trevisani. Identification of Two Clinical Hepatocellular Carcinoma Patient Phenotypes From Results of Standard Screening ParametersSeminars in Oncology 2014; 41(3): 406 doi: 10.1053/j.seminoncol.2014.04.002
82
Pierre Bedossa, Valérie Paradis. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract2012; : 1223 doi: 10.1016/B978-1-4377-1454-8.00078-3
83
Armin Thelen, Arne Scholz, Christoph Benckert, Zofia von Marschall, Maik Schröder, Bertram Wiedenmann, Peter Neuhaus, Stefan Rosewicz, Sven Jonas. VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinomaInternational Journal of Cancer 2008; 122(11): 2471 doi: 10.1002/ijc.23439
84
Zenta Walther, Dhanpat Jain. Molecular Pathology of Hepatic Neoplasms: Classification and Clinical SignificancePathology Research International 2011; 2011: 1 doi: 10.4061/2011/403929
85
O Scatton, F Chiappini, P Riou, A Marconi, R Saffroy, M-P Bralet, D Azoulay, C Boucheix, B Debuire, G Uzan, A Lemoine. Fate and characterization of circulating tumor cells in a NOD/SCID mouse model of human hepatocellular carcinomaOncogene 2006; 25(29): 4067 doi: 10.1038/sj.onc.1209430
86
Lunxiu Qin, Zhaoyou Tang, Xinyuan Guan, Qinghai Ye, Huliang Jia, Ning Ren. The predictive value of chromosome 8p deletion for metastasis of hepatocellular carcinoma: a summary of works in 10 yearsFrontiers of Medicine in China 2008; 2(3): 211 doi: 10.1007/s11684-008-0041-y
87
Atsushi Nanashima, Syuuichi Tobinaga, Masaki Kunizaki, Satoshi Miuma, Naota Taura, Hiroaki Takeshita, Shigekazu Hidaka, Terumitsu Sawai, Kazuhiko Nakao, Takeshi Nagayasu. Strategy of treatment for hepatocellular Carcinomas with vascular infiltration in patients undergoing hepatectomyJournal of Surgical Oncology 2010; 101(7): 557 doi: 10.1002/jso.21534
88
Ruo-Cai Xu, Han-Chun Liu, Jian-Liang Li, Ke Li, Shuang-Yan Ou, Zhi-Yuan Yu, Yi Kong, Guo-An Ma, Wei-Shu Shao. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinomaCurrent Medical Research and Opinion 2015; 31(8): 1553 doi: 10.1185/03007995.2015.1058249
89
Ming-Chin Yu, Kun-Ming Chan, Chen-Fang Lee, Yun-Shien Lee, Firas Zahr Eldeen, Hong-Shiue Chou, Wei-Chen Lee, Miin-Fu Chen. Alkaline Phosphatase: Does it have a Role in Predicting Hepatocellular Carcinoma Recurrence?Journal of Gastrointestinal Surgery 2011; 15(8): 1440 doi: 10.1007/s11605-011-1537-3
90
Yiyu Lu, Zhaoyuan Fang, Meiyi Li, Qian Chen, Tao Zeng, Lina Lu, Qilong Chen, Hui Zhang, Qianmei Zhou, Yan Sun, Xuefeng Xue, Yiyang Hu, Luonan Chen, Shibing Su, Jiarui Wu. Dynamic edge-based biomarker non-invasively predicts hepatocellular carcinoma with hepatitis B virus infection for individual patients based on blood testingJournal of Molecular Cell Biology 2019; 11(8): 665 doi: 10.1093/jmcb/mjz025
91
Eun Shin, Han Suk Ryu, Soo-Hee Kim, Haeyoen Jung, Ja-June Jang, Kyoungbun Lee. The clinicopathological significance of heat shock protein 70 and glutamine synthetase expression in hepatocellular carcinomaJournal of Hepato-Biliary-Pancreatic Sciences 2011; 18(4): 544 doi: 10.1007/s00534-010-0367-0
92
MASATAKE TANAKA, YUKO MASAKI, KOSUKE TANAKA, MASAYUKI MIYAZAKI, MASAKI KATO, RIE SUGIMOTO, KAZUHIKO NAKAMURA, SHINICHI AISHIMA, KEN SHIRABE, MAKOTO NAKAMUTA, MUNECHIKA ENJOJI, KAZUHIRO KOTOH, RYOICHI TAKAYANAGI. Reduction of fatty acid oxidation and responses to hypoxia correlate with the progression of de-differentiation in HCCMolecular Medicine Reports 2013; 7(2): 365 doi: 10.3892/mmr.2012.1201
93
Vito Longo, Oronzo Brunetti, Stella D’Oronzo, Carmela Ostuni, Pietro Gatti, Franco Silvestris. Bone metastases in hepatocellular carcinoma: an emerging issueCancer and Metastasis Reviews 2014; 33(1): 333 doi: 10.1007/s10555-013-9454-4
94
Fu-Hua Yan, Kang-Rong Zhou, Jie-Min Cheng, Jian-Hua Wang, Zhi-Ping Yan, Reng-Rong Da, Jia Fan, Yuan Ji. Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACEWorld Journal of Gastroenterology 2002; 8(4): 658-662 doi: 10.3748/wjg.v8.i4.658
95
Aziz Zaanan, Nicolas Williet, Mohamed Hebbar, Tienhan Sandrine Dabakuyo, Laetitia Fartoux, Touraj Mansourbakht, Olivier Dubreuil, Olivier Rosmorduc, Stéphane Cattan, Franck Bonnetain, Valérie Boige, Julien Taïeb. Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: A large multicenter AGEO studyJournal of Hepatology 2013; 58(1): 81 doi: 10.1016/j.jhep.2012.09.006
96
Chen-Guo Ker, Hong-Yaw Chen, Hsi-Jung Chen, I-Hao Tseng, Yu-Jou Tsai, Hoi-Wan Lo, Chung-Chou Juan. Challenge of safety margin in laparoscopic liver resection for hepatocellular carcinomaFormosan Journal of Surgery 2014; 47(5): 183 doi: 10.1016/j.fjs.2014.08.005
97
Xiao-Bo Man, Liang Tang, Xiu-Hua Qiu, Li-Qun Yang, Hui-Fang Cao, Meng-Chao Wu, Hong-Yang Wang. Expression of <italic>cytochrome P4502E1</italic> gene in hepatocellular carcinomaWorld Journal of Gastroenterology 2004; 10(11): 1565-1568 doi: 10.3748/wjg.v10.i11.1565
98
Ke-Jun Nan, Zhao Jing, Ling Gong. Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27<sup>Kip1</sup> in hepatocellular carcinomaWorld Journal of Gastroenterology 2004; 10(10): 1425-1430 doi: 10.3748/wjg.v10.i10.1425
99
Chen-Guo Ker. Surgical safety margin of gastroenterological cancer surgery: A truth or a dream?Formosan Journal of Surgery 2014; 47(3): 83 doi: 10.1016/j.fjs.2013.07.004
100
A. ZIMMERMANN. Surgery of the Liver, Biliary Tract and Pancreas2007; : 1085 doi: 10.1016/B978-1-4160-3256-4.50082-X
101
Lei Xu, Shuo Wu, Jun Wang. Cancer cell membrane–coated nanocarriers for homologous target inhibiting the growth of hepatocellular carcinomaJournal of Bioactive and Compatible Polymers 2019; 34(1): 58 doi: 10.1177/0883911518819107
102
Shama C. Buch, Venkateswarlu Kondragunta, Robert A. Branch, Brian I. Carr. Gender-based outcomes differences in unresectable hepatocellular carcinomaHepatology International 2008; 2(1): 95 doi: 10.1007/s12072-007-9041-2
103
Frank Tacke, Georg Brabant, Elmar Kruck, Rüdiger Horn, Patrick Schöffski, Hartmut Hecker, Michael P Manns, Christian Trautwein. Ghrelin in chronic liver diseaseJournal of Hepatology 2003; 38(4): 447 doi: 10.1016/S0168-8278(02)00438-5
104
Lei Xu, Shuo Wu, Xiaoqiu Zhou. Bioinspired nanocarriers for an effective chemotherapy of hepatocellular carcinomaJournal of Biomaterials Applications 2018; 33(1): 72 doi: 10.1177/0885328218772721
105
Kuo-Feng Hsu, Jyh-Cherng Yu, Chih-Wei Yang, Bao-Chung Chen, Cheng-Jueng Chen, De-Chuan Chan, Hsiu-Lung Fan, Teng-Wei Chen, Yu-Lueng Shih, Tsai-Yuan Hsieh, Chung-Bao Hsieh. Long-term outcomes in elderly patients with resectable large hepatocellular carcinoma undergoing hepatectomySurgical Oncology 2018; 27(3): 595 doi: 10.1016/j.suronc.2018.07.009
106
Zhen-Yu Yin, Xiao-Ming Wang, Ren-Xiang Yu, Bai-Meng Zhang, Ke-Ke Yu, Ning Li, Jie-Shou Li. Total vascular exclusion technique for resection of hepatocellular carcinomaWorld Journal of Gastroenterology 2003; 9(10): 2194-2197 doi: 10.3748/wjg.v9.i10.2194
107
Young Kon Kim, Young Hwan Lee, Chong Soo Kim, Young Min Han, Seung Bae Hwang. Double-dose 1.0-M gadobutrol versus standard-dose 0.5-M gadopentetate dimeglumine in revealing small hypervascular hepatocellular carcinomasEuropean Radiology 2008; 18(1): 70 doi: 10.1007/s00330-007-0630-1
108
Xiao-Hui Huang, Qian Wang, Jing-Song Chen, Xin-Hui Fu, Xi-Lin Chen, Lian-Zhou Chen, Wen Li, Jiong Bi, Long-Juan Zhang, Qian Fu, Wen-Tao Zeng, Liang-Qi Cao, Hao-Xiang Tan, Qiao Su. Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulatedHepatology Research 2009; 39(8): 786 doi: 10.1111/j.1872-034X.2009.00502.x
109
Lun-Xiu Qin, Zhao-You Tang. The prognostic molecular markers in hepatocellular carcinomaWorld Journal of Gastroenterology 2002; 8(3): 385-392 doi: 10.3748/wjg.v8.i3.385
110
Diego F. Calvisi, Valentina M. Factor, Sara Ladu, Elizabeth A. Conner, Snorri S. Thorgeirsson. Disruption of β-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic miceGastroenterology 2004; 126(5): 1374 doi: 10.1053/j.gastro.2004.02.014
111
Zhenghong Xu, Lingli Chen, Wangwen Gu, Yu Gao, Liping Lin, Zhiwen Zhang, Yong Xi, Yaping Li. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinomaBiomaterials 2009; 30(2): 226 doi: 10.1016/j.biomaterials.2008.09.014
112
Antonio Moral, José Magarzo. Marcadores tumorales serológicos en cirugía hepatobiliopancreáticaCirugía Española 2004; 76(5): 276 doi: 10.1016/S0009-739X(04)72378-7